Literature DB >> 9353736

Laser desorption mass spectrometry.

W T Moore1.   

Abstract

The examples presented indicate that MALDI-MS is a useful tool for evaluating the progress of peptide synthesis at all the necessary levels: automated assembly, cleavage and deprotection chemistries, RP-HPLC analyses and purifications, and structural validation of the final product. The technique, if judiciously applied, permits the evaluation of complex peptide mixtures and often provides a semiquantitative overview. We have found that the availability of this method has enabled the provision of high-quality peptide reagents for use in the local research environment. The integration of this methodology into our peptide synthesis facility has also enabled and encouraged us to undertake more challenging synthetic problems such as phosphopeptide synthesis, peptide cyclizations, and peptide modification chemistries that would not ordinarily be offered if the laboratory lacked this technology. MALDI-MS is one of the more versatile and readily integrable mass spectrometric methods that can be incorporated into the average peptide synthesis laboratory.

Mesh:

Substances:

Year:  1997        PMID: 9353736     DOI: 10.1016/s0076-6879(97)89062-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.

Authors:  M R Sarrias; J C Whitbeck; I Rooney; L Spruce; B K Kay; R I Montgomery; P G Spear; C F Ware; R J Eisenberg; G H Cohen; J D Lambris
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.

Authors:  Andrew N Hoofnagle; Jeffrey R Whiteaker; Steven A Carr; Eric Kuhn; Tao Liu; Sam A Massoni; Stefani N Thomas; R Reid Townsend; Lisa J Zimmerman; Emily Boja; Jing Chen; Daniel L Crimmins; Sherri R Davies; Yuqian Gao; Tara R Hiltke; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Matthew R Meyer; Wei-Jun Qian; Regine M Schoenherr; Mitchell G Scott; Tujin Shi; Gordon R Whiteley; John A Wrobel; Chaochao Wu; Brad L Ackermann; Ruedi Aebersold; David R Barnidge; David M Bunk; Nigel Clarke; Jordan B Fishman; Russ P Grant; Ulrike Kusebauch; Mark M Kushnir; Mark S Lowenthal; Robert L Moritz; Hendrik Neubert; Scott D Patterson; Alan L Rockwood; John Rogers; Ravinder J Singh; Jennifer E Van Eyk; Steven H Wong; Shucha Zhang; Daniel W Chan; Xian Chen; Matthew J Ellis; Daniel C Liebler; Karin D Rodland; Henry Rodriguez; Richard D Smith; Zhen Zhang; Hui Zhang; Amanda G Paulovich
Journal:  Clin Chem       Date:  2016-01       Impact factor: 8.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.